BNB Plus (BNBX) Revenue & Revenue Breakdown
BNB Plus Revenue Highlights
Latest Revenue (Y)
$3.43M
Latest Revenue (Q)
$304.39K
BNB Plus Revenue by Period
BNB Plus Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $3.43M | -74.33% |
| 2023-09-30 | $13.37M | -26.43% |
| 2022-09-30 | $18.17M | 101.25% |
| 2021-09-30 | $9.03M | - |
BNB Plus generated $3.43M in revenue during NA 2024, up -74.33% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
BNB Plus Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $304.39K | -69.05% |
| 2025-03-31 | $983.37K | -17.82% |
| 2024-12-31 | $1.20M | 47.17% |
| 2024-09-30 | $813.11K | 71.98% |
| 2024-06-30 | $472.79K | - |
BNB Plus generated $304.39K in revenue during Q3 2025, up -69.05% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
BNB Plus Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VERO | Venus Concept | $64.83M | - |
| BNGO | Bionano Genomics | $30.78M | $6.73M |
| ISPC | iSpecimen | $9.29M | $106.59K |
| RDHL | RedHill Biopharma | $6.51M | $1.80M |
| BNBX | BNB Plus | $3.43M | $304.39K |
| NAOV | NanoVibronix | $2.28M | - |
| BGMS | Bio Green Med Solution | $43.00K | - |
| KZIA | Kazia Therapeutics | $555.00 | $5.00 |
| NDRA | ENDRA Life Sciences | - | - |